Standout Papers

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritrop... 1986 2026 1999 2012 5.5k
  1. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. (1986)
    Yasuhiro Matsumura, Hiroshi Maeda PubMed
  2. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review (2000)
    Hiroshi Maeda, Jun Wu et al. Journal of Controlled Release
  3. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect (2010)
    Jun Fang, Hideaki Nakamura et al. Advanced Drug Delivery Reviews
  4. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo (2012)
    Hiroshi Maeda, Hideaki Nakamura et al. Advanced Drug Delivery Reviews
  5. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting (2001)
    Hiroshi Maeda Advances in Enzyme Regulation
  6. Exploiting the enhanced permeability and retention effect for tumor targeting (2006)
    Arun K. Iyer, Khaled Greish et al. Drug Discovery Today
  7. Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology (2013)
    Uma Prabhakar, Hiroshi Maeda et al. Cancer Research
  8. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity (2015)
    Hiroshi Maeda Advanced Drug Delivery Reviews
  9. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect (2008)
    Hiroshi Maeda, Gahininath Y. Bharate et al. European Journal of Pharmaceutics and Biopharmaceutics
  10. Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects (2010)
    Hiroshi Maeda Bioconjugate Chemistry
  11. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS (2001)
    Hiroshi Maeda, Tomohiro Sawa et al. Journal of Controlled Release
  12. Macromolecular therapeutics in cancer treatment: The EPR effect and beyond (2012)
    Hiroshi Maeda Journal of Controlled Release
  13. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers (2020)
    Jun Fang, Waliul Islam et al. Advanced Drug Delivery Reviews
  14. Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/.bul.NO (nitric oxide) through a radical reaction (1993)
    Takaaki Akaike, Masaki Yoshida et al. Biochemistry

Immediate Impact

5 by Nobel laureates 6 from Science/Nature 310 standout
Sub-graph 1 of 16

Citing Papers

Biomedicine Meets Fenton Chemistry
2021 Standout
Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1
2019 Standout
28 intermediate papers

Works of Hiroshi Maeda being referenced

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting
2001 Standout
Induction of haem oxygenase-1 by nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth
1999
and 17 more

Author Peers

Author Last Decade Papers Cites
Hiroshi Maeda 14227 18599 3478 15511 241 36.7k
Ick Chan Kwon 12467 14739 3774 13537 441 33.2k
Omid C. Farokhzad 24450 28771 4113 28044 218 61.1k
Vladimir P. Torchilin 16709 15503 3208 9619 181 30.9k
Samir Mitragotri 13489 13187 3556 16135 352 46.7k
Gert Storm 12910 12299 1850 9698 437 30.0k
Zhen Gu 13415 10095 1894 17236 379 37.8k
Kwangmeyung Kim 9811 11011 2193 11859 376 25.2k
Yasuhiro Matsumura 8600 11341 2282 7983 255 22.8k
Patrick Couvreur 15868 21951 6722 15729 573 54.9k
Xing‐Jie Liang 12353 9738 2340 15186 459 32.1k

All Works

Loading papers...

Rankless by CCL
2026